Radiotherapy and Chemotherapy Risks in Childhood Cancer Survivors
Author Information
Author(s): F. de Vathaire, P. Franqois, C. Hill, O. Schweisguth, C. Rodary, D. Sarrazin, O. Oberlin, C. Beurtheret, A. Dutreix, R. Flamant
Primary Institution: Institut Gustave Roussy
Hypothesis
Does the dose of radiotherapy and the use of chemotherapy increase the risk of second malignant neoplasms in childhood cancer survivors?
Conclusion
The study suggests that high doses of radiotherapy combined with chemotherapy significantly increase the risk of second malignant neoplasms in children treated for cancer.
Supporting Evidence
- 32 out of 634 children developed second malignant neoplasms after treatment for a first cancer.
- Children who received 50Gy or more of radiotherapy had a relative risk of 5.8 for developing second malignant neoplasms.
- Chemotherapy increased the relative risk of second malignant neoplasms to 2.7.
- Dactinomycin was found to significantly increase the risk of second soft tissue and bone sarcomas.
Takeaway
Kids who had cancer and got radiation or chemotherapy might get another cancer later. The more radiation and the combination with chemotherapy, the higher the risk.
Methodology
A case-control study was performed on a cohort of 634 children treated for a first cancer, comparing those who developed second malignant neoplasms with matched controls.
Potential Biases
Potential biases may arise from retrospective data collection and matching criteria.
Limitations
The study relies on historical treatment data, which may not be complete or accurate.
Participant Demographics
The cohort included 634 children under 17 years old, with 32 developing second malignant neoplasms; 17 were males and 15 were females.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 1.2-6.4
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website